Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?

Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?

Bibliographic Details
Main Authors:	Bannakij Lojanapiwat, Masatoshi Eto, Paul Mainwaring
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Series:	Prostate International
Online Access:	http://www.sciencedirect.com/science/article/pii/S2287888215300933

Similar Items

Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice
by: Bannakij Lojanapiwat
Published: (2014-09-01)

Supracostal access: does it affect tubeless percutaneous nephrolithotomy efficacy and safety?
by: J. Jun-Ou, et al.
Published: (2010-04-01)

ADTs, data structures, and problem solving with C++ /
by: 252203 Nyhoff, Larry R.
Published: (2005)

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study
by: Hiroji Uemura, et al.
Published: (2022-01-01)

Standing Still and Cutting in Line
by: Ajay Gandhi
Published: (2013-03-01)

Synthesis of Recursive ADT Transformations from Reusable Templates
by: Qiu, Xiaokang, et al.
Published: (2017)

Mastering VIZ render : a resource for autodesk ADT users /
by: 437278 Aubin, Paul F., et al.
Published: (2005)

An On-line System for Algebraic Manipulation
by: Fenichel, Robert R.
Published: (2023)

FedADT: An Adaptive Method Based on Derivative Term for Federated Learning
by: Huimin Gao, et al.
Published: (2023-06-01)

The X-2 ADT-X: Japan's last chance fighter jet?
by: Bitzinger, Richard A.
Published: (2016)

Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
by: Zeina Ayoub, et al.
Published: (2022-12-01)

Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity
by: Masatoshi Kudo
Published: (2023-01-01)

This house believes that sulphonylureas should not be used routinely as second-line treatments for patients with type 2 diabetes
by: Ryder, R, et al.
Published: (2016)

Line Kinematics for Whole-Arm Manipulation
by: Eberman, Brian, et al.
Published: (2004)

Mastering VIZ render [compact disc] : a resource for autodesk ADT users /
by: 437278 Aubin, Paul F., et al.
Published: (2005)

Estimation of average daily traffic (ADT) using hourly volume for roads in UTM /
by: Kamarul Irsyaduddin Kamarulzaman , 1996-, author, et al.
Published: (2019)

Estimation of average daily traffic (ADT) using hourly volume for roads in UTM /
by: Kamarul Irsyaduddin Kamarulzaman, 1996- , author, et al.
Published: (2019)

SHOULD THE TEETH IN THE LINE OF JAW FRACTURES BE EXTRACTED?
by: Mert TAYŞİ, et al.
Published: (2015-01-01)

Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials
by: Julianne M. Falotico, et al.
Published: (2022-03-01)

ADT‐OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells
by: Huangru Xu, et al.
Published: (2023-08-01)

A method to produce high contrast vein visualization in active dynamic thermography (ADT)
by: Saxena, Ashish, et al.
Published: (2022)

Genetic manipulation of an Ixodes scapularis cell line
by: Nisha Singh, et al.
Published: (2024-03-01)

Benefits of remote control on the railway lines
by: Lukáš Křižan, et al.
Published: (2023-11-01)

Soybean AROGENATE DEHYDRATASES (GmADTs): involvement in the cytosolic isoflavonoid metabolon or trans-organelle continuity?
by: Emily J. Clayton, et al.
Published: (2024-01-01)

Fault lines : how hidden fractures still threaten the world economy /
by: 488368 Rajan, Raghuram G.
Published: (2010)

A pandemic 'to be or not to be'- we should still be ready for monkeypox
by: Sonu Hangma Subba
Published: (2022-01-01)

Biochemical recurrence related metabolic novel signature associates with immunity and ADT treatment responses in prostate cancer
by: Xuan Wang, et al.
Published: (2023-01-01)

Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done
by: Marzia Mare, et al.
Published: (2022-09-01)

Why should we invest in health? Evidence from the lens of second-order benefits of health
by: Delfin Lovelina Francis, et al.
Published: (2023-08-01)

Why is the prevailing model of joint manipulation (still) incorrect?
by: David W. Evans
Published: (2022-12-01)

Should patients undergoing PCI still be consented for emergency bypass?
by: Arnold, JR, et al.
Published: (2009)

Should we still use nitrovasodilators to test baroreflex sensitivity?
by: Casadei, B, et al.
Published: (2000)

The Pulmonary Artery Catheter in the Perioperative Setting: Should It Still Be Used?
by: Thomas Senoner, et al.
Published: (2022-01-01)

Should Codeine Still be Considered a WHO Essential Medicine?
by: Boni Singu, et al.
Published: (2021-06-01)

Congenital toxoplasmosis: Should we still care about screening?
by: Eskild Petersen, et al.
Published: (2022-06-01)

Daily egg consumption should be still limited in hypercholestrolemic patients
by: Cheng-Wei Liu
Published: (2017-12-01)

Application and comparison of on-line identification methods for flexible manipulator control /
by: 320258 Tzes, Anthony P., et al.

Model parameter on-line identification with nonlinear parametrization – manipulator model
by: Cedro Leszek
Published: (2022-01-01)

Kinematics Analysis and Simulation of Line-driven Hedge Trimming Manipulator
by: Xue Zan, et al.
Published: (2019-01-01)

A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer
by: Hanqiao Shao, et al.
Published: (2024-01-01)